| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cognition Disorders | 114 | 2023 | 1003 | 11.510 |
Why?
|
| Aging | 110 | 2025 | 1549 | 10.170 |
Why?
|
| Alzheimer Disease | 126 | 2025 | 2118 | 8.880 |
Why?
|
| Cognitive Dysfunction | 65 | 2025 | 1065 | 7.530 |
Why?
|
| Cognition | 94 | 2023 | 1352 | 6.930 |
Why?
|
| Aged, 80 and over | 221 | 2025 | 4851 | 5.620 |
Why?
|
| Longitudinal Studies | 128 | 2025 | 1384 | 5.610 |
Why?
|
| Dementia | 37 | 2022 | 573 | 5.580 |
Why?
|
| Aged | 271 | 2025 | 9256 | 5.400 |
Why?
|
| Neuropsychological Tests | 100 | 2022 | 1226 | 4.120 |
Why?
|
| Brain | 58 | 2023 | 1663 | 4.110 |
Why?
|
| Male | 271 | 2025 | 15269 | 4.050 |
Why?
|
| Female | 271 | 2025 | 15704 | 3.990 |
Why?
|
| Humans | 313 | 2025 | 28395 | 3.430 |
Why?
|
| Olfaction Disorders | 8 | 2021 | 49 | 3.010 |
Why?
|
| Memory | 23 | 2018 | 302 | 2.740 |
Why?
|
| Lewy Bodies | 10 | 2021 | 194 | 2.520 |
Why?
|
| Depression | 21 | 2016 | 452 | 2.490 |
Why?
|
| Memory, Episodic | 10 | 2022 | 116 | 2.450 |
Why?
|
| Cohort Studies | 68 | 2024 | 1926 | 2.380 |
Why?
|
| Disease Progression | 36 | 2021 | 717 | 2.290 |
Why?
|
| Educational Status | 25 | 2023 | 298 | 2.080 |
Why?
|
| Decision Making | 13 | 2023 | 226 | 2.040 |
Why?
|
| Personality | 7 | 2015 | 54 | 1.950 |
Why?
|
| Stress, Psychological | 11 | 2021 | 241 | 1.940 |
Why?
|
| Memory Disorders | 11 | 2019 | 162 | 1.930 |
Why?
|
| DNA-Binding Proteins | 9 | 2019 | 274 | 1.820 |
Why?
|
| Independent Living | 17 | 2025 | 318 | 1.660 |
Why?
|
| Apolipoprotein E4 | 21 | 2025 | 264 | 1.580 |
Why?
|
| Risk Factors | 64 | 2023 | 2408 | 1.560 |
Why?
|
| Cognitive Aging | 8 | 2021 | 78 | 1.530 |
Why?
|
| Chicago | 44 | 2025 | 939 | 1.480 |
Why?
|
| Apolipoproteins E | 20 | 2023 | 252 | 1.470 |
Why?
|
| Health Literacy | 8 | 2023 | 108 | 1.440 |
Why?
|
| Neurodegenerative Diseases | 5 | 2021 | 124 | 1.400 |
Why?
|
| Follow-Up Studies | 42 | 2020 | 1858 | 1.390 |
Why?
|
| Loneliness | 9 | 2025 | 61 | 1.290 |
Why?
|
| Mortality | 11 | 2021 | 90 | 1.270 |
Why?
|
| Interpersonal Relations | 8 | 2014 | 100 | 1.260 |
Why?
|
| Motor Activity | 18 | 2015 | 329 | 1.240 |
Why?
|
| Autopsy | 18 | 2021 | 343 | 1.240 |
Why?
|
| Hospitalization | 5 | 2019 | 323 | 1.210 |
Why?
|
| Cerebral Infarction | 8 | 2015 | 148 | 1.210 |
Why?
|
| Incidence | 31 | 2025 | 773 | 1.160 |
Why?
|
| Geriatric Assessment | 24 | 2017 | 211 | 1.130 |
Why?
|
| Lewy Body Disease | 6 | 2021 | 100 | 1.120 |
Why?
|
| Middle Aged | 49 | 2021 | 9250 | 1.020 |
Why?
|
| Learning | 2 | 2018 | 73 | 1.010 |
Why?
|
| Neurofibrillary Tangles | 10 | 2017 | 193 | 1.010 |
Why?
|
| Anxiety | 4 | 2013 | 161 | 1.000 |
Why?
|
| Activities of Daily Living | 23 | 2013 | 608 | 0.980 |
Why?
|
| Memory, Short-Term | 6 | 2019 | 100 | 0.970 |
Why?
|
| Age Factors | 26 | 2021 | 781 | 0.950 |
Why?
|
| Hippocampus | 8 | 2022 | 278 | 0.950 |
Why?
|
| Parkinsonian Disorders | 9 | 2019 | 226 | 0.930 |
Why?
|
| Neurotic Disorders | 6 | 2018 | 19 | 0.920 |
Why?
|
| Age of Onset | 5 | 2022 | 99 | 0.900 |
Why?
|
| Proportional Hazards Models | 23 | 2019 | 352 | 0.900 |
Why?
|
| United States | 33 | 2023 | 2196 | 0.890 |
Why?
|
| Substantia Nigra | 4 | 2021 | 124 | 0.890 |
Why?
|
| Death | 5 | 2021 | 47 | 0.860 |
Why?
|
| Perception | 4 | 2021 | 78 | 0.860 |
Why?
|
| Neurons | 4 | 2013 | 342 | 0.860 |
Why?
|
| Delay Discounting | 1 | 2023 | 24 | 0.850 |
Why?
|
| Cerebral Cortex | 3 | 2021 | 161 | 0.830 |
Why?
|
| Risk | 19 | 2019 | 205 | 0.830 |
Why?
|
| Nervous System Diseases | 5 | 2023 | 121 | 0.830 |
Why?
|
| Prospective Studies | 35 | 2025 | 1804 | 0.820 |
Why?
|
| Agnosia | 2 | 2016 | 9 | 0.820 |
Why?
|
| Odorants | 4 | 2010 | 22 | 0.800 |
Why?
|
| Exercise | 9 | 2023 | 473 | 0.790 |
Why?
|
| Life Style | 5 | 2021 | 201 | 0.790 |
Why?
|
| Amyloid beta-Peptides | 7 | 2023 | 327 | 0.760 |
Why?
|
| Genetic Predisposition to Disease | 12 | 2017 | 390 | 0.760 |
Why?
|
| Disabled Persons | 7 | 2019 | 125 | 0.760 |
Why?
|
| Amygdala | 1 | 2021 | 41 | 0.730 |
Why?
|
| Research Design | 5 | 2020 | 207 | 0.730 |
Why?
|
| Psychomotor Performance | 9 | 2021 | 212 | 0.720 |
Why?
|
| Choice Behavior | 2 | 2019 | 46 | 0.710 |
Why?
|
| Language | 3 | 2014 | 71 | 0.710 |
Why?
|
| Neocortex | 2 | 2019 | 31 | 0.680 |
Why?
|
| Olfactory Bulb | 1 | 2019 | 17 | 0.660 |
Why?
|
| Genotype | 19 | 2022 | 359 | 0.660 |
Why?
|
| Child Abuse | 2 | 2012 | 35 | 0.650 |
Why?
|
| Anxiety Disorders | 3 | 2016 | 171 | 0.650 |
Why?
|
| Chronic Disease | 5 | 2017 | 441 | 0.640 |
Why?
|
| Severity of Illness Index | 16 | 2021 | 985 | 0.640 |
Why?
|
| Prodromal Symptoms | 1 | 2019 | 18 | 0.630 |
Why?
|
| Reward | 1 | 2019 | 23 | 0.630 |
Why?
|
| Music | 2 | 2021 | 24 | 0.630 |
Why?
|
| Cognitive Reserve | 1 | 2019 | 39 | 0.610 |
Why?
|
| Reading | 5 | 2021 | 37 | 0.610 |
Why?
|
| Psychiatric Status Rating Scales | 12 | 2016 | 324 | 0.600 |
Why?
|
| Comorbidity | 15 | 2020 | 500 | 0.580 |
Why?
|
| Awareness | 4 | 2019 | 45 | 0.560 |
Why?
|
| Brain Stem | 2 | 2016 | 19 | 0.550 |
Why?
|
| Depressive Disorder | 4 | 2019 | 185 | 0.550 |
Why?
|
| Ambulatory Care | 1 | 2017 | 74 | 0.540 |
Why?
|
| Locus Coeruleus | 2 | 2013 | 21 | 0.530 |
Why?
|
| Cross-Sectional Studies | 18 | 2022 | 932 | 0.530 |
Why?
|
| Brain Diseases | 3 | 2020 | 67 | 0.530 |
Why?
|
| Urban Population | 4 | 2013 | 157 | 0.530 |
Why?
|
| Mobility Limitation | 7 | 2019 | 94 | 0.510 |
Why?
|
| Brain Chemistry | 1 | 2016 | 44 | 0.510 |
Why?
|
| Alleles | 13 | 2023 | 221 | 0.500 |
Why?
|
| Blood Pressure | 6 | 2022 | 207 | 0.500 |
Why?
|
| Motor Skills | 2 | 2013 | 52 | 0.490 |
Why?
|
| Longevity | 2 | 2013 | 30 | 0.490 |
Why?
|
| Plaque, Amyloid | 7 | 2017 | 146 | 0.490 |
Why?
|
| Depressive Disorder, Major | 1 | 2016 | 102 | 0.480 |
Why?
|
| Biomarkers | 7 | 2023 | 596 | 0.480 |
Why?
|
| Frail Elderly | 5 | 2014 | 53 | 0.450 |
Why?
|
| Multilingualism | 1 | 2014 | 21 | 0.450 |
Why?
|
| Quality of Life | 3 | 2015 | 658 | 0.450 |
Why?
|
| Sex Factors | 13 | 2020 | 475 | 0.440 |
Why?
|
| Time Factors | 16 | 2021 | 1490 | 0.440 |
Why?
|
| Mesencephalon | 1 | 2013 | 26 | 0.440 |
Why?
|
| Mental Recall | 6 | 2020 | 63 | 0.430 |
Why?
|
| Disability Evaluation | 12 | 2015 | 289 | 0.430 |
Why?
|
| tau Proteins | 7 | 2023 | 235 | 0.430 |
Why?
|
| Delivery of Health Care | 5 | 2023 | 154 | 0.420 |
Why?
|
| Population Surveillance | 5 | 2021 | 110 | 0.420 |
Why?
|
| Neuropathology | 5 | 2022 | 82 | 0.410 |
Why?
|
| Personal Satisfaction | 1 | 2013 | 44 | 0.410 |
Why?
|
| Membrane Transport Proteins | 3 | 2017 | 57 | 0.410 |
Why?
|
| TDP-43 Proteinopathies | 3 | 2020 | 110 | 0.390 |
Why?
|
| Emotions | 1 | 2012 | 78 | 0.390 |
Why?
|
| Movement Disorders | 4 | 2021 | 90 | 0.390 |
Why?
|
| Mental Status and Dementia Tests | 6 | 2023 | 69 | 0.390 |
Why?
|
| Mental Health | 2 | 2016 | 122 | 0.380 |
Why?
|
| Brazil | 5 | 2021 | 39 | 0.370 |
Why?
|
| Family | 3 | 2021 | 115 | 0.370 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2018 | 191 | 0.370 |
Why?
|
| Residence Characteristics | 9 | 2015 | 214 | 0.360 |
Why?
|
| Sclerosis | 4 | 2020 | 66 | 0.360 |
Why?
|
| Muscle Strength | 6 | 2009 | 136 | 0.360 |
Why?
|
| Knowledge | 1 | 2010 | 16 | 0.350 |
Why?
|
| Reaction Time | 3 | 2020 | 106 | 0.350 |
Why?
|
| Telephone | 1 | 2010 | 29 | 0.350 |
Why?
|
| Family Health | 1 | 2010 | 36 | 0.350 |
Why?
|
| Diet | 4 | 2010 | 220 | 0.340 |
Why?
|
| Social Class | 3 | 2022 | 66 | 0.340 |
Why?
|
| Social Isolation | 3 | 2025 | 29 | 0.340 |
Why?
|
| Psychological Tests | 4 | 2013 | 53 | 0.340 |
Why?
|
| Prefrontal Cortex | 3 | 2021 | 137 | 0.340 |
Why?
|
| Linear Models | 12 | 2017 | 251 | 0.330 |
Why?
|
| Tissue Donors | 2 | 2020 | 84 | 0.330 |
Why?
|
| Diagnosis, Differential | 1 | 2011 | 372 | 0.330 |
Why?
|
| Psychometrics | 11 | 2012 | 244 | 0.330 |
Why?
|
| Risk Assessment | 11 | 2022 | 676 | 0.320 |
Why?
|
| Mental Status Schedule | 9 | 2017 | 93 | 0.320 |
Why?
|
| Literacy | 2 | 2021 | 16 | 0.320 |
Why?
|
| Interviews as Topic | 3 | 2021 | 139 | 0.320 |
Why?
|
| Life | 2 | 2006 | 6 | 0.320 |
Why?
|
| Clergy | 11 | 2013 | 92 | 0.310 |
Why?
|
| Income | 5 | 2023 | 77 | 0.310 |
Why?
|
| Cerebral Amyloid Angiopathy | 3 | 2015 | 113 | 0.310 |
Why?
|
| Parkinson Disease | 7 | 2017 | 844 | 0.300 |
Why?
|
| Adult | 16 | 2023 | 8097 | 0.300 |
Why?
|
| Models, Psychological | 5 | 2015 | 77 | 0.300 |
Why?
|
| Antioxidants | 3 | 2005 | 64 | 0.300 |
Why?
|
| Logistic Models | 8 | 2017 | 395 | 0.290 |
Why?
|
| Social Support | 4 | 2014 | 215 | 0.290 |
Why?
|
| Stroke | 3 | 2016 | 274 | 0.290 |
Why?
|
| Language Tests | 2 | 2013 | 33 | 0.290 |
Why?
|
| Neurologic Examination | 3 | 2020 | 114 | 0.290 |
Why?
|
| Day Care, Medical | 1 | 2007 | 7 | 0.280 |
Why?
|
| Homes for the Aged | 1 | 2007 | 10 | 0.280 |
Why?
|
| Feeding Behavior | 2 | 2005 | 92 | 0.280 |
Why?
|
| Surveys and Questionnaires | 10 | 2020 | 1215 | 0.280 |
Why?
|
| Nursing Homes | 1 | 2007 | 37 | 0.280 |
Why?
|
| Financial Management | 2 | 2020 | 23 | 0.280 |
Why?
|
| Dietary Fats | 2 | 2006 | 38 | 0.270 |
Why?
|
| Community Health Planning | 3 | 2011 | 21 | 0.270 |
Why?
|
| Self Report | 4 | 2022 | 221 | 0.270 |
Why?
|
| Vitamin E | 3 | 2005 | 44 | 0.270 |
Why?
|
| Intelligence | 1 | 2006 | 19 | 0.270 |
Why?
|
| Social Behavior | 5 | 2011 | 67 | 0.260 |
Why?
|
| Decision Support Techniques | 1 | 2006 | 52 | 0.260 |
Why?
|
| Smell | 2 | 2016 | 17 | 0.260 |
Why?
|
| Personality Disorders | 1 | 2006 | 16 | 0.260 |
Why?
|
| Health Status | 8 | 2019 | 224 | 0.260 |
Why?
|
| Risk-Taking | 1 | 2006 | 35 | 0.260 |
Why?
|
| Prevalence | 6 | 2023 | 467 | 0.260 |
Why?
|
| Membrane Proteins | 2 | 2021 | 171 | 0.260 |
Why?
|
| Neuroticism | 4 | 2023 | 32 | 0.260 |
Why?
|
| Fraud | 3 | 2022 | 21 | 0.260 |
Why?
|
| Delusions | 1 | 2005 | 10 | 0.250 |
Why?
|
| Fish Products | 1 | 2005 | 2 | 0.250 |
Why?
|
| Fishes | 1 | 2005 | 4 | 0.250 |
Why?
|
| Child | 5 | 2020 | 1421 | 0.250 |
Why?
|
| Intermediate Filaments | 2 | 2022 | 20 | 0.250 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2022 | 1143 | 0.250 |
Why?
|
| Models, Statistical | 6 | 2021 | 129 | 0.250 |
Why?
|
| Reproducibility of Results | 7 | 2012 | 733 | 0.240 |
Why?
|
| Hallucinations | 1 | 2005 | 64 | 0.240 |
Why?
|
| Factor Analysis, Statistical | 3 | 2015 | 63 | 0.240 |
Why?
|
| Genetic Variation | 3 | 2017 | 97 | 0.240 |
Why?
|
| Diet Surveys | 2 | 2006 | 25 | 0.240 |
Why?
|
| Vehicle Emissions | 1 | 2024 | 5 | 0.240 |
Why?
|
| Mood Disorders | 1 | 2005 | 31 | 0.240 |
Why?
|
| Air Pollutants | 1 | 2024 | 11 | 0.240 |
Why?
|
| Air Pollution | 1 | 2024 | 16 | 0.240 |
Why?
|
| Environmental Exposure | 1 | 2024 | 17 | 0.240 |
Why?
|
| Space Perception | 2 | 2019 | 24 | 0.240 |
Why?
|
| Lipids | 1 | 2025 | 52 | 0.240 |
Why?
|
| Predictive Value of Tests | 7 | 2021 | 492 | 0.230 |
Why?
|
| Particulate Matter | 1 | 2024 | 20 | 0.230 |
Why?
|
| Sensitivity and Specificity | 4 | 2021 | 517 | 0.230 |
Why?
|
| Nutrition Disorders | 1 | 2003 | 3 | 0.220 |
Why?
|
| Personality Inventory | 4 | 2009 | 73 | 0.220 |
Why?
|
| Life Change Events | 2 | 2014 | 38 | 0.220 |
Why?
|
| Hypertension | 3 | 2022 | 244 | 0.220 |
Why?
|
| White Matter | 2 | 2022 | 134 | 0.220 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2016 | 284 | 0.220 |
Why?
|
| Anger | 1 | 2003 | 31 | 0.220 |
Why?
|
| Prognosis | 5 | 2020 | 825 | 0.210 |
Why?
|
| Affect | 1 | 2003 | 59 | 0.210 |
Why?
|
| Gait Disorders, Neurologic | 5 | 2009 | 138 | 0.210 |
Why?
|
| Diabetes Complications | 3 | 2016 | 59 | 0.210 |
Why?
|
| Social Adjustment | 3 | 2009 | 26 | 0.210 |
Why?
|
| Cause of Death | 2 | 2021 | 64 | 0.210 |
Why?
|
| Catholicism | 5 | 2013 | 20 | 0.200 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2006 | 235 | 0.200 |
Why?
|
| Vitamin A | 1 | 2002 | 8 | 0.200 |
Why?
|
| Carotenoids | 1 | 2002 | 18 | 0.200 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2020 | 42 | 0.200 |
Why?
|
| Social Participation | 1 | 2022 | 12 | 0.200 |
Why?
|
| Leg | 3 | 2007 | 52 | 0.200 |
Why?
|
| Self Stimulation | 1 | 2002 | 8 | 0.200 |
Why?
|
| Antihypertensive Agents | 3 | 2020 | 81 | 0.200 |
Why?
|
| Radar | 1 | 2022 | 6 | 0.200 |
Why?
|
| Crime Victims | 1 | 2022 | 33 | 0.190 |
Why?
|
| National Institute on Aging (U.S.) | 1 | 2022 | 17 | 0.190 |
Why?
|
| Reference Values | 3 | 2020 | 194 | 0.190 |
Why?
|
| Metacognition | 1 | 2021 | 4 | 0.190 |
Why?
|
| Cerebrovascular Disorders | 3 | 2020 | 134 | 0.190 |
Why?
|
| Cerebral Arterial Diseases | 1 | 2021 | 9 | 0.190 |
Why?
|
| Elder Abuse | 1 | 2022 | 36 | 0.190 |
Why?
|
| Health Behavior | 3 | 2020 | 165 | 0.190 |
Why?
|
| Statistics, Nonparametric | 4 | 2015 | 128 | 0.190 |
Why?
|
| Social Discrimination | 1 | 2021 | 7 | 0.180 |
Why?
|
| Memory and Learning Tests | 1 | 2020 | 7 | 0.180 |
Why?
|
| Epidemiologic Studies | 3 | 2012 | 24 | 0.180 |
Why?
|
| Serial Learning | 1 | 2020 | 7 | 0.180 |
Why?
|
| Social Segregation | 1 | 2020 | 7 | 0.180 |
Why?
|
| Neurofilament Proteins | 1 | 2020 | 17 | 0.180 |
Why?
|
| Peptides | 1 | 2021 | 103 | 0.180 |
Why?
|
| Socioeconomic Factors | 5 | 2018 | 308 | 0.180 |
Why?
|
| Synapses | 2 | 2012 | 36 | 0.170 |
Why?
|
| Muscle Rigidity | 3 | 2014 | 21 | 0.170 |
Why?
|
| Musculoskeletal Diseases | 2 | 2010 | 46 | 0.170 |
Why?
|
| Health Equity | 1 | 2020 | 18 | 0.170 |
Why?
|
| Frailty | 1 | 2020 | 35 | 0.170 |
Why?
|
| Child Development | 1 | 2020 | 75 | 0.170 |
Why?
|
| Neurocognitive Disorders | 1 | 2019 | 13 | 0.160 |
Why?
|
| Confidence Intervals | 7 | 2017 | 95 | 0.160 |
Why?
|
| Smoking | 3 | 2012 | 176 | 0.160 |
Why?
|
| Metabolic Syndrome | 1 | 2020 | 62 | 0.160 |
Why?
|
| Cardiovascular Diseases | 2 | 2017 | 372 | 0.160 |
Why?
|
| Social Environment | 2 | 2012 | 81 | 0.160 |
Why?
|
| Visual Perception | 2 | 2011 | 30 | 0.160 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2018 | 6 | 0.160 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2019 | 26 | 0.160 |
Why?
|
| Haplotypes | 2 | 2017 | 59 | 0.160 |
Why?
|
| Primary Prevention | 1 | 2019 | 35 | 0.160 |
Why?
|
| Emergencies | 1 | 2019 | 36 | 0.160 |
Why?
|
| Economics | 1 | 2018 | 17 | 0.150 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2018 | 55 | 0.150 |
Why?
|
| Odds Ratio | 6 | 2017 | 268 | 0.150 |
Why?
|
| Blood Glucose | 1 | 2018 | 108 | 0.150 |
Why?
|
| Parents | 2 | 2012 | 126 | 0.150 |
Why?
|
| Illinois | 5 | 2020 | 246 | 0.150 |
Why?
|
| Genome-Wide Association Study | 3 | 2016 | 283 | 0.150 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2019 | 81 | 0.150 |
Why?
|
| Gait | 5 | 2014 | 412 | 0.140 |
Why?
|
| Osteoporosis | 1 | 2018 | 76 | 0.140 |
Why?
|
| Urinary Incontinence | 1 | 2017 | 23 | 0.140 |
Why?
|
| Neoplasms | 2 | 2018 | 239 | 0.140 |
Why?
|
| Brain Infarction | 3 | 2016 | 75 | 0.140 |
Why?
|
| Polymorphism, Genetic | 1 | 2017 | 62 | 0.140 |
Why?
|
| Pain | 2 | 2010 | 405 | 0.140 |
Why?
|
| Apolipoprotein E3 | 1 | 2017 | 16 | 0.140 |
Why?
|
| Homozygote | 1 | 2017 | 21 | 0.140 |
Why?
|
| Gene Expression | 1 | 2018 | 202 | 0.140 |
Why?
|
| Education | 3 | 2006 | 46 | 0.140 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 185 | 0.140 |
Why?
|
| Child, Preschool | 2 | 2022 | 689 | 0.130 |
Why?
|
| Biostatistics | 1 | 2016 | 5 | 0.130 |
Why?
|
| Prejudice | 2 | 2008 | 34 | 0.130 |
Why?
|
| Statistics as Topic | 4 | 2017 | 107 | 0.130 |
Why?
|
| Copper | 2 | 2024 | 18 | 0.130 |
Why?
|
| Employment | 1 | 2016 | 45 | 0.130 |
Why?
|
| Attention | 3 | 2005 | 131 | 0.120 |
Why?
|
| Age Distribution | 3 | 2011 | 89 | 0.120 |
Why?
|
| Motor Disorders | 1 | 2015 | 23 | 0.120 |
Why?
|
| Empathy | 1 | 2014 | 43 | 0.120 |
Why?
|
| Harm Reduction | 1 | 2014 | 6 | 0.110 |
Why?
|
| Dancing | 1 | 2014 | 14 | 0.110 |
Why?
|
| Heterozygote | 3 | 2025 | 102 | 0.110 |
Why?
|
| Raphe Nuclei | 1 | 2013 | 7 | 0.110 |
Why?
|
| Ventral Tegmental Area | 1 | 2013 | 9 | 0.110 |
Why?
|
| Locomotion | 1 | 2014 | 24 | 0.110 |
Why?
|
| Regression Analysis | 5 | 2018 | 266 | 0.110 |
Why?
|
| Cell Count | 1 | 2013 | 79 | 0.110 |
Why?
|
| Survival Analysis | 2 | 2005 | 267 | 0.110 |
Why?
|
| Religion | 1 | 2013 | 42 | 0.110 |
Why?
|
| Cholinergic Antagonists | 1 | 2013 | 11 | 0.110 |
Why?
|
| Nerve Degeneration | 1 | 2013 | 49 | 0.100 |
Why?
|
| Hypokinesia | 2 | 2014 | 23 | 0.100 |
Why?
|
| Medicare | 3 | 2019 | 121 | 0.100 |
Why?
|
| Health Status Disparities | 1 | 2013 | 74 | 0.100 |
Why?
|
| Religion and Psychology | 2 | 2010 | 24 | 0.100 |
Why?
|
| Health Promotion | 1 | 2014 | 162 | 0.100 |
Why?
|
| Young Adult | 3 | 2013 | 2069 | 0.100 |
Why?
|
| Anomie | 1 | 2012 | 3 | 0.100 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2012 | 15 | 0.100 |
Why?
|
| Hydrocortisone | 1 | 2012 | 40 | 0.100 |
Why?
|
| Patient Dropouts | 1 | 2012 | 28 | 0.100 |
Why?
|
| Personality Assessment | 3 | 2006 | 36 | 0.100 |
Why?
|
| Association | 1 | 2011 | 7 | 0.100 |
Why?
|
| Bias | 1 | 2012 | 41 | 0.100 |
Why?
|
| Insulin Resistance | 1 | 2012 | 52 | 0.100 |
Why?
|
| HIV Infections | 1 | 2017 | 488 | 0.090 |
Why?
|
| Tremor | 2 | 2014 | 117 | 0.090 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2012 | 59 | 0.090 |
Why?
|
| Guanylate Kinases | 1 | 2011 | 2 | 0.090 |
Why?
|
| Post-Synaptic Density | 1 | 2011 | 2 | 0.090 |
Why?
|
| Corticosterone | 1 | 2011 | 3 | 0.090 |
Why?
|
| Retrospective Studies | 3 | 2021 | 3609 | 0.090 |
Why?
|
| Microfilament Proteins | 1 | 2011 | 24 | 0.090 |
Why?
|
| Receptors, Complement 3b | 1 | 2011 | 15 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 1 | 2012 | 155 | 0.090 |
Why?
|
| Endophenotypes | 1 | 2011 | 11 | 0.090 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2011 | 26 | 0.090 |
Why?
|
| Wechsler Scales | 2 | 2010 | 10 | 0.090 |
Why?
|
| Motor Skills Disorders | 1 | 2010 | 16 | 0.090 |
Why?
|
| Genetic Association Studies | 3 | 2017 | 85 | 0.090 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2010 | 5 | 0.090 |
Why?
|
| Cost-Benefit Analysis | 1 | 2011 | 134 | 0.090 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2010 | 19 | 0.090 |
Why?
|
| Adolescent | 2 | 2013 | 2307 | 0.080 |
Why?
|
| Body Mass Index | 3 | 2023 | 465 | 0.080 |
Why?
|
| Immunohistochemistry | 4 | 2017 | 362 | 0.080 |
Why?
|
| Self Care | 1 | 2010 | 105 | 0.080 |
Why?
|
| Somatosensory Disorders | 1 | 2009 | 11 | 0.080 |
Why?
|
| Hostility | 1 | 2009 | 21 | 0.080 |
Why?
|
| Sensory Thresholds | 1 | 2009 | 23 | 0.080 |
Why?
|
| Life Expectancy | 1 | 2009 | 28 | 0.080 |
Why?
|
| Diet, Mediterranean | 1 | 2010 | 101 | 0.080 |
Why?
|
| Vibration | 1 | 2009 | 30 | 0.080 |
Why?
|
| Financing, Personal | 2 | 2019 | 20 | 0.080 |
Why?
|
| Caspase 3 | 1 | 2008 | 20 | 0.080 |
Why?
|
| Amyloid | 2 | 2010 | 56 | 0.080 |
Why?
|
| Differential Threshold | 1 | 2008 | 3 | 0.080 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2005 | 21 | 0.080 |
Why?
|
| Sex Characteristics | 2 | 2022 | 118 | 0.070 |
Why?
|
| Hemoglobins | 1 | 2008 | 78 | 0.070 |
Why?
|
| ROC Curve | 2 | 2022 | 144 | 0.070 |
Why?
|
| Survival Rate | 1 | 2009 | 356 | 0.070 |
Why?
|
| Data Collection | 2 | 2005 | 98 | 0.070 |
Why?
|
| Executive Function | 2 | 2021 | 115 | 0.070 |
Why?
|
| Hand Strength | 1 | 2007 | 60 | 0.070 |
Why?
|
| Personal Space | 1 | 2007 | 7 | 0.070 |
Why?
|
| Perceptual Disorders | 1 | 2006 | 5 | 0.070 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 111 | 0.070 |
Why?
|
| Latin America | 1 | 2006 | 5 | 0.070 |
Why?
|
| Likelihood Functions | 2 | 2017 | 27 | 0.070 |
Why?
|
| Trans Fatty Acids | 1 | 2006 | 4 | 0.070 |
Why?
|
| Spouses | 1 | 2006 | 27 | 0.070 |
Why?
|
| Dyskinesias | 1 | 2006 | 21 | 0.070 |
Why?
|
| Ambulatory Care Facilities | 1 | 2006 | 40 | 0.070 |
Why?
|
| Fatty Acids | 1 | 2006 | 41 | 0.070 |
Why?
|
| Fear | 1 | 2006 | 46 | 0.070 |
Why?
|
| Disease Susceptibility | 1 | 2006 | 75 | 0.070 |
Why?
|
| Urban Health | 1 | 2006 | 22 | 0.060 |
Why?
|
| Psychology | 1 | 2006 | 23 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 3 | 2016 | 83 | 0.060 |
Why?
|
| Parent-Child Relations | 1 | 2006 | 40 | 0.060 |
Why?
|
| Population Groups | 1 | 2005 | 7 | 0.060 |
Why?
|
| Patient Readmission | 1 | 2007 | 133 | 0.060 |
Why?
|
| Verbal Learning | 2 | 2004 | 34 | 0.060 |
Why?
|
| Parkinson Disease, Secondary | 1 | 2005 | 9 | 0.060 |
Why?
|
| DNA | 1 | 2005 | 104 | 0.060 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2006 | 122 | 0.060 |
Why?
|
| Molar, Third | 1 | 2005 | 1 | 0.060 |
Why?
|
| Dentin-Bonding Agents | 1 | 2005 | 1 | 0.060 |
Why?
|
| Dental Etching | 1 | 2005 | 1 | 0.060 |
Why?
|
| Eating | 1 | 2005 | 59 | 0.060 |
Why?
|
| Dentin | 1 | 2005 | 2 | 0.060 |
Why?
|
| Energy Intake | 1 | 2005 | 82 | 0.060 |
Why?
|
| Family Characteristics | 1 | 2005 | 18 | 0.060 |
Why?
|
| Tocopherols | 1 | 2005 | 9 | 0.060 |
Why?
|
| Parenting | 1 | 2006 | 81 | 0.060 |
Why?
|
| Water | 1 | 2005 | 32 | 0.060 |
Why?
|
| Nitrogen Dioxide | 1 | 2024 | 4 | 0.060 |
Why?
|
| Nitrogen Oxides | 1 | 2024 | 4 | 0.060 |
Why?
|
| Triglycerides | 1 | 2025 | 61 | 0.060 |
Why?
|
| Cholesterol | 1 | 2025 | 64 | 0.060 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2005 | 48 | 0.060 |
Why?
|
| Sex Distribution | 3 | 2011 | 82 | 0.060 |
Why?
|
| Zinc | 1 | 2024 | 47 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2006 | 320 | 0.060 |
Why?
|
| Postural Balance | 3 | 2014 | 122 | 0.060 |
Why?
|
| Markov Chains | 2 | 2015 | 32 | 0.050 |
Why?
|
| Brain Mapping | 3 | 2012 | 150 | 0.050 |
Why?
|
| Florida | 1 | 2023 | 22 | 0.050 |
Why?
|
| Seafood | 1 | 2003 | 13 | 0.050 |
Why?
|
| Brief Psychiatric Rating Scale | 2 | 2015 | 7 | 0.050 |
Why?
|
| Sleep | 1 | 2006 | 355 | 0.050 |
Why?
|
| Animals | 2 | 2011 | 3780 | 0.050 |
Why?
|
| Health Surveys | 2 | 2013 | 88 | 0.050 |
Why?
|
| Frontal Lobe | 1 | 2002 | 81 | 0.050 |
Why?
|
| Reactive Oxygen Species | 1 | 2022 | 119 | 0.050 |
Why?
|
| Atrophy | 1 | 2021 | 93 | 0.050 |
Why?
|
| Mathematics | 1 | 2021 | 31 | 0.050 |
Why?
|
| Cost of Illness | 1 | 2021 | 53 | 0.050 |
Why?
|
| Attitude to Death | 1 | 2020 | 12 | 0.040 |
Why?
|
| Writing | 1 | 2021 | 22 | 0.040 |
Why?
|
| Interview, Psychological | 2 | 2014 | 42 | 0.040 |
Why?
|
| Late Onset Disorders | 1 | 2020 | 6 | 0.040 |
Why?
|
| Southeastern United States | 1 | 2020 | 14 | 0.040 |
Why?
|
| Tissue and Organ Procurement | 1 | 2020 | 35 | 0.040 |
Why?
|
| Early Diagnosis | 1 | 2020 | 67 | 0.040 |
Why?
|
| Midwestern United States | 1 | 2020 | 62 | 0.040 |
Why?
|
| Focus Groups | 1 | 2020 | 93 | 0.040 |
Why?
|
| Intelligence Tests | 2 | 2014 | 15 | 0.040 |
Why?
|
| Neuroimaging | 1 | 2020 | 128 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2011 | 148 | 0.040 |
Why?
|
| Nutrition Assessment | 3 | 2005 | 44 | 0.040 |
Why?
|
| Minority Groups | 1 | 2020 | 86 | 0.040 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2019 | 18 | 0.040 |
Why?
|
| Muscle Strength Dynamometer | 2 | 2009 | 18 | 0.040 |
Why?
|
| Proteomics | 1 | 2019 | 93 | 0.040 |
Why?
|
| Religious Personnel | 1 | 2018 | 11 | 0.040 |
Why?
|
| Epidemiologic Research Design | 2 | 2010 | 15 | 0.040 |
Why?
|
| Dementia, Vascular | 1 | 2018 | 45 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 137 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2018 | 432 | 0.040 |
Why?
|
| Diagnosis | 1 | 2017 | 24 | 0.040 |
Why?
|
| Genetic Linkage | 1 | 2017 | 58 | 0.040 |
Why?
|
| Genotyping Techniques | 1 | 2017 | 9 | 0.030 |
Why?
|
| Tuberous Sclerosis | 1 | 2017 | 15 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2016 | 40 | 0.030 |
Why?
|
| Anisotropy | 1 | 2016 | 47 | 0.030 |
Why?
|
| Inflammation | 1 | 2018 | 284 | 0.030 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2016 | 63 | 0.030 |
Why?
|
| Demography | 1 | 2016 | 73 | 0.030 |
Why?
|
| Arteriolosclerosis | 1 | 2016 | 77 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 169 | 0.030 |
Why?
|
| Pattern Recognition, Visual | 2 | 2005 | 18 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2016 | 199 | 0.030 |
Why?
|
| Self Efficacy | 1 | 2014 | 59 | 0.030 |
Why?
|
| Medicare Part D | 1 | 2013 | 7 | 0.030 |
Why?
|
| Dietary Supplements | 2 | 2005 | 67 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 166 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2014 | 358 | 0.030 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2012 | 12 | 0.030 |
Why?
|
| Protein Array Analysis | 1 | 2012 | 10 | 0.020 |
Why?
|
| Thiazoles | 1 | 2012 | 19 | 0.020 |
Why?
|
| Phosphoserine | 1 | 2012 | 5 | 0.020 |
Why?
|
| Cerebellar Cortex | 1 | 2012 | 7 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2012 | 25 | 0.020 |
Why?
|
| Multilevel Analysis | 1 | 2012 | 7 | 0.020 |
Why?
|
| Temporal Lobe | 1 | 2012 | 84 | 0.020 |
Why?
|
| Aniline Compounds | 1 | 2012 | 36 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2012 | 39 | 0.020 |
Why?
|
| Drug Resistance | 1 | 2012 | 47 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2012 | 42 | 0.020 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 7 | 1 | 2011 | 3 | 0.020 |
Why?
|
| Glucose | 1 | 2012 | 55 | 0.020 |
Why?
|
| Causality | 1 | 2011 | 56 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2012 | 149 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2012 | 89 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 2011 | 42 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2012 | 213 | 0.020 |
Why?
|
| Insulin | 1 | 2012 | 90 | 0.020 |
Why?
|
| Disks Large Homolog 4 Protein | 1 | 2011 | 4 | 0.020 |
Why?
|
| Niacinamide | 1 | 2011 | 6 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2012 | 183 | 0.020 |
Why?
|
| Nutrition Policy | 1 | 2010 | 9 | 0.020 |
Why?
|
| Trail Making Test | 1 | 2010 | 4 | 0.020 |
Why?
|
| Wine | 1 | 2010 | 7 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 269 | 0.020 |
Why?
|
| Dendritic Spines | 1 | 2010 | 9 | 0.020 |
Why?
|
| Dendrites | 1 | 2010 | 10 | 0.020 |
Why?
|
| Piperazines | 1 | 2011 | 80 | 0.020 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2010 | 29 | 0.020 |
Why?
|
| Retirement | 1 | 2009 | 12 | 0.020 |
Why?
|
| Internet | 1 | 2011 | 98 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2012 | 447 | 0.020 |
Why?
|
| Mechanoreceptors | 1 | 2009 | 7 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2011 | 435 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2010 | 164 | 0.020 |
Why?
|
| Proprioception | 1 | 2009 | 21 | 0.020 |
Why?
|
| Synaptosomes | 1 | 2008 | 8 | 0.020 |
Why?
|
| Tissue Extracts | 1 | 2008 | 9 | 0.020 |
Why?
|
| Joints | 1 | 2009 | 69 | 0.020 |
Why?
|
| Protein Transport | 1 | 2008 | 32 | 0.020 |
Why?
|
| Ergometry | 1 | 2008 | 3 | 0.020 |
Why?
|
| Cytosol | 1 | 2008 | 43 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2008 | 79 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2008 | 120 | 0.020 |
Why?
|
| Algorithms | 1 | 2011 | 377 | 0.020 |
Why?
|
| Observation | 1 | 2007 | 12 | 0.020 |
Why?
|
| Aspirin | 1 | 2008 | 84 | 0.020 |
Why?
|
| Visual Acuity | 1 | 2007 | 39 | 0.020 |
Why?
|
| Psychotropic Drugs | 1 | 2007 | 27 | 0.020 |
Why?
|
| Range of Motion, Articular | 1 | 2010 | 704 | 0.020 |
Why?
|
| Mice | 1 | 2011 | 1461 | 0.020 |
Why?
|
| Forecasting | 1 | 2006 | 103 | 0.020 |
Why?
|
| Verbal Behavior | 1 | 2005 | 16 | 0.020 |
Why?
|
| Photic Stimulation | 1 | 2005 | 27 | 0.020 |
Why?
|
| Cross-Cultural Comparison | 1 | 2005 | 39 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2009 | 397 | 0.020 |
Why?
|
| Community Mental Health Centers | 1 | 2005 | 5 | 0.020 |
Why?
|
| Cultural Diversity | 1 | 2005 | 29 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2005 | 44 | 0.020 |
Why?
|
| Acid Etching, Dental | 1 | 2005 | 2 | 0.020 |
Why?
|
| Hardness | 1 | 2005 | 5 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2005 | 63 | 0.020 |
Why?
|
| Tissue Adhesions | 1 | 2005 | 11 | 0.020 |
Why?
|
| Elasticity | 1 | 2005 | 31 | 0.020 |
Why?
|
| Cementation | 1 | 2005 | 33 | 0.020 |
Why?
|
| gamma-Tocopherol | 1 | 2005 | 9 | 0.020 |
Why?
|
| alpha-Tocopherol | 1 | 2005 | 13 | 0.020 |
Why?
|
| Logic | 1 | 2004 | 2 | 0.020 |
Why?
|
| Heart Failure | 1 | 2007 | 179 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2005 | 176 | 0.010 |
Why?
|
| Surface Properties | 1 | 2005 | 140 | 0.010 |
Why?
|
| Cues | 1 | 2004 | 43 | 0.010 |
Why?
|
| Health Status Indicators | 1 | 2005 | 75 | 0.010 |
Why?
|
| Comprehension | 1 | 2004 | 30 | 0.010 |
Why?
|
| Materials Testing | 1 | 2005 | 136 | 0.010 |
Why?
|
| Sick Role | 1 | 2004 | 16 | 0.010 |
Why?
|
| Probability | 1 | 2004 | 90 | 0.010 |
Why?
|
| Speech Perception | 1 | 2004 | 53 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2003 | 29 | 0.010 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2003 | 9 | 0.010 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2003 | 11 | 0.010 |
Why?
|
| Docosahexaenoic Acids | 1 | 2003 | 11 | 0.010 |
Why?
|
| Walking | 1 | 2005 | 259 | 0.010 |
Why?
|
| beta Carotene | 1 | 2002 | 12 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2002 | 46 | 0.010 |
Why?
|
| Ascorbic Acid | 1 | 2002 | 41 | 0.010 |
Why?
|
| Dominance, Cerebral | 1 | 2002 | 16 | 0.010 |
Why?
|
| Hypotension | 1 | 2002 | 29 | 0.010 |
Why?
|
| Semantics | 1 | 2002 | 15 | 0.010 |
Why?
|
| Arousal | 1 | 2002 | 50 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2002 | 107 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2002 | 331 | 0.010 |
Why?
|